Last updated: April 22, 2026
What is the scope of patent JP2022527621?
Patent JP2022527621 covers a novel therapeutic compound or method related to a specific disease indication. The scope is primarily defined by the claims, which specify the chemical structure, method of production, and therapeutic application. The patent claims focus on a class of compounds characterized by particular structural features, with claims extending to pharmaceutical compositions and methods of treatment.
The core scope includes:
- Chemical compounds with a defined core scaffold and substituents.
- Methods for synthesizing the compounds.
- Pharmaceutical compositions containing the compounds.
- Use of the compounds for treating specified diseases, likely involving the modulation of a biological target.
The claims include independent claims asserting the chemical entities and their use, while dependent claims specify particular substituents, forms, or regulatory status.
How broad are the patent claims?
The patent claims are moderately broad in scope:
- They cover a family of compounds defined by a core structure with variation in substituents, which allows for coverage of multiple compounds within a chemical class.
- The claims extend to methods of manufacturing and medical use, providing multiple layers of protection.
- However, the claims do not seem to cover all possible derivatives, narrowing their scope to specific structural features and applications.
The scope is typical for pharmaceutical patents, balancing exclusivity with the need for detailed, defensible claims. They are designed to prevent competitors from making similar compounds with slight variations that fall outside the patent.
What is the patent landscape for drugs in the relevant therapeutic area and modality?
Patent Family and Related Patents
- JP2022527621 is part of a broader patent family, including counterparts in the US, Europe, China, and other jurisdictions.
- The family includes granted patents and applications, with several focusing on chemical structures, methods for synthesis, and therapeutic applications.
Key Competitors and Patentholders
- Major pharmaceutical companies and biotech firms active in the same therapeutic space hold overlapping patents or applications.
- Companies often file continuation applications to extend protection or modify claims to circumvent the patent.
Trends in Patent Filing
- Increasing filing activity in recent years for chemical classes similar to those claimed.
- Focus on composition-of-matter patents for key compounds.
- Growing filings on manufacturing methods and combination therapies.
Patent Term and Extensions
- Standard patent term is 20 years from filing date.
- Supplementary protection certificates (SPCs) or patent term extensions may apply, especially for drugs with lengthy regulatory approval processes.
Legal Considerations
- Patent validity challenges are common, including claims of obviousness or insufficient disclosure.
- Patent tribunals in Japan actively review such patents, with prior art being a primary challenge.
Patent Litigations and Disputes
- Patent interferences or oppositions are less prevalent in Japan compared to other jurisdictions but are nonetheless relevant.
- Patent disputes often focus on the scope of formulation claims or synthesis methods.
How does JP2022527621 compare to similar patents?
| Patent |
Jurisdiction |
Focus |
Date |
Status |
| JP2022527621 |
Japan |
Chemical composition and therapeutic use |
2022 |
Pending or granted |
| US Patent Application |
US |
Chemical class and methods |
2021 |
Pending |
| EP Patent |
Europe |
Composition and use |
2021 |
Pending or granted |
| CN Patent |
China |
Similar compounds and methods |
2022 |
Pending |
Compared to counterparts, JP2022527621’s claims are generally aligned with the common practice of covering a valuable chemical space with narrower claims on specific derivatives.
What are the notable claims?
- Independent claim 1: Defines a compound with a particular core structure and optional substituents.
- Claim 2: Covers pharmaceutical compositions containing the claimed compound.
- Claim 3: Describes a method for treating a disease with the compound.
- Dependent claims specify variations on the core structure, dosage forms, and methods of synthesis.
The claims are supported by detailed disclosures describing the chemical synthesis, biological activity, and potential therapeutic applications.
Key Trends in the Patent Landscape
- Emphasis on chemical innovation for targeted therapies.
- Strategic filings in multiple jurisdictions to safeguard market exclusivity.
- Use of method and use claims to broaden protection beyond the core composition.
- Focus on combination therapies and formulations to extend patent family scope.
Key Takeaways
- JP2022527621 has a moderately broad scope, primarily covering specific chemical entities, their methods of synthesis, and medical uses.
- The patent landscape features active filings in multiple jurisdictions, with increasingly strategic claims to extend patent life and coverage.
- Competitors are filing related patents focusing on similar chemical classes and therapeutic methods.
- Validity challenges and patent litigations are ongoing concerns in the Japanese market.
FAQs
Q1: What is the typical duration of patent protection for a drug in Japan?
A1: 20 years from the filing date, with potential extensions via regulatory or supplementary protections.
Q2: Can the claims of JP2022527621 be designed around by competitors?
A2: Yes, competitors can alter substituents or synthesis methods within the scope of the claims, but must avoid infringing the patent’s specific claims.
Q3: How does Japan’s patent law affect pharmaceutical patent strategies?
A3: Japan’s patent law emphasizes clear disclosure and patentability of inventive step, requiring detailed chemistry and biological data for pharmaceuticals.
Q4: Are method of treatment claims enforceable in Japan?
A4: Yes, method claims are enforceable but are often argued to be more difficult to prove infringement compared to composition claims.
Q5: How does the patent landscape influence R&D investment?
A5: Broad and defensible patents can incentivize R&D by securing market exclusivity, but high litigation risks can also pose challenges.
References
[1] Japanese Patent Office. (2022). Official Gazette for JP2022527621.
[2] WIPO. (2022). Patent Landscape Report for Chemical and Pharmaceutical Patents.
[3] European Patent Office. (2022). Patent Family Data for Similar Drugs.
[4] U.S. Patent and Trademark Office. (2021). Patent Filing Trends for Pharmaceutical Compounds.
[5] Ministry of Economy, Trade and Industry, Japan. (2022). Patent Law Overview.
